FHD-286: Clinical Trials

1 trial of FHD-286, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow FHD-286: new trials by email Literature Review of FHD-286 trials Research Report on FHD-286

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SMARCA4/2 Inhibitor for POU2F3-Positive SCLC
FHD-286 - Small Cell Lung Cancer
Phase 2RecruitingDana-Farber Cancer Institute202026-04-282026-10-26

Conditions studied

Small Cell Lung Carcinoma (1)

Sponsors

Dana-Farber Cancer Institute (1)

Countries

United States (1)

Top investigators

Alissa Cooper (1)